Cargando…
_version_ 1783696214079832064
author Harrington, Patrick
de Lavallade, Hugues
Doores, Katie J.
O’Reilly, Amy
Seow, Jeffrey
Graham, Carl
Lechmere, Thomas
Radia, Deepti
Dillon, Richard
Shanmugharaj, Yogita
Espehana, Andreas
Woodley, Claire
Saunders, Jamie
Curto-Garcia, Natalia
O’Sullivan, Jennifer
Raj, Kavita
Kordasti, Shahram
Malim, Michael H.
Harrison, Claire N.
McLornan, Donal P.
author_facet Harrington, Patrick
de Lavallade, Hugues
Doores, Katie J.
O’Reilly, Amy
Seow, Jeffrey
Graham, Carl
Lechmere, Thomas
Radia, Deepti
Dillon, Richard
Shanmugharaj, Yogita
Espehana, Andreas
Woodley, Claire
Saunders, Jamie
Curto-Garcia, Natalia
O’Sullivan, Jennifer
Raj, Kavita
Kordasti, Shahram
Malim, Michael H.
Harrison, Claire N.
McLornan, Donal P.
author_sort Harrington, Patrick
collection PubMed
description
format Online
Article
Text
id pubmed-8140572
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81405722021-05-24 Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms Harrington, Patrick de Lavallade, Hugues Doores, Katie J. O’Reilly, Amy Seow, Jeffrey Graham, Carl Lechmere, Thomas Radia, Deepti Dillon, Richard Shanmugharaj, Yogita Espehana, Andreas Woodley, Claire Saunders, Jamie Curto-Garcia, Natalia O’Sullivan, Jennifer Raj, Kavita Kordasti, Shahram Malim, Michael H. Harrison, Claire N. McLornan, Donal P. Leukemia Letter Nature Publishing Group UK 2021-05-22 2021 /pmc/articles/PMC8140572/ /pubmed/34023850 http://dx.doi.org/10.1038/s41375-021-01300-7 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter
Harrington, Patrick
de Lavallade, Hugues
Doores, Katie J.
O’Reilly, Amy
Seow, Jeffrey
Graham, Carl
Lechmere, Thomas
Radia, Deepti
Dillon, Richard
Shanmugharaj, Yogita
Espehana, Andreas
Woodley, Claire
Saunders, Jamie
Curto-Garcia, Natalia
O’Sullivan, Jennifer
Raj, Kavita
Kordasti, Shahram
Malim, Michael H.
Harrison, Claire N.
McLornan, Donal P.
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title_full Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title_fullStr Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title_full_unstemmed Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title_short Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
title_sort single dose of bnt162b2 mrna vaccine against sars-cov-2 induces high frequency of neutralising antibody and polyfunctional t-cell responses in patients with myeloproliferative neoplasms
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140572/
https://www.ncbi.nlm.nih.gov/pubmed/34023850
http://dx.doi.org/10.1038/s41375-021-01300-7
work_keys_str_mv AT harringtonpatrick singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT delavalladehugues singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT dooreskatiej singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT oreillyamy singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT seowjeffrey singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT grahamcarl singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT lechmerethomas singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT radiadeepti singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT dillonrichard singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT shanmugharajyogita singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT espehanaandreas singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT woodleyclaire singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT saundersjamie singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT curtogarcianatalia singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT osullivanjennifer singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT rajkavita singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT kordastishahram singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT malimmichaelh singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT harrisonclairen singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms
AT mclornandonalp singledoseofbnt162b2mrnavaccineagainstsarscov2induceshighfrequencyofneutralisingantibodyandpolyfunctionaltcellresponsesinpatientswithmyeloproliferativeneoplasms